An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin
Clinical trial NCT02290301 · COMPLETED
Trial details
- NCT number
- NCT02290301
- Sponsor
- LG Life Sciences
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-06-28
- Primary completion
- 2017-11-30
- Enrollment
- 5180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.